CROLIUS CLAYTON (Chief Financial Officer) received a stock award from DNA X, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/10/2026ACC: 0001493152-26-006055
Officer· Chief Financial Officer
Since Jul 2022
+35K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
35K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+35K
Price / share
—
Trade value
—
% of position
2036.1%
2/9/2026
1.72K→36.72K
Total
Net shares
+35K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/9/2026 | A · Award | +35K | — | — | 2036.1% | 1.72K | 36.72K |
| Total | +35K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported